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Abstract: For patients exposed to a massive blood loss during surgery,
maintained coagulation competence is important. It is less obvious
whether coagulation competence influences bleeding during elective
surgery where patients are exposed to infusion of a crystalloid or a
colloid.
This randomized controlled trial evaluates whether administration
of 5% human albumin (HA) or lactated Ringer solution (LR) affects
coagulation competence and in turn blood loss during cystectomy due to
bladder cancer.
Forty patients undergoing radical cystectomy were included tohnau, MD, Tom P DMSc,
er, MD, DMSc
Blinded determination of the blood loss was similar in the 2 groups
of patients: 1658 (800–3300)mL with the use of HA and 1472 (700–
4330)mL in the lactated Ringer group (P¼ 0.45). Yet, by thrombe-
lastography (TEG) evaluated coagulation competence, albumin
affected clot growth (TEG-angle 69 5 vs 748 38, P< 0.01) and
strength (TEG-MA: 59 6 vs 67 6mm, P< 0.001) more than LR.
Furthermore, by multivariate linear regression analyses reduced TEG-
MA was independently associated with the blood loss (P¼ 0.042)
while administration of albumin was related to the changes in TEG-
MA (P¼ 0.029), aPPT (P< 0.022), and INR (P< 0.033).
This randomized controlled trial demonstrates that administration of
HA does not affect the blood loss as compared to infusion of LR. Also the
use of HA did not affect the need for blood transfusion, the incidence of
postoperative complications, or the hospital in-stay. Yet, albumin
decreases coagulation competence during major surgery and the blood
loss is related to TEG-MA rather than to plasma coagulation variables.
(Medicine 95(9):e2720)
Abbreviations: GDT = goal directed fluid therapy, HA = human
albumin, LR = lactated Ringer solution, Ly30 = Lysis after 30min,
TEG = thrombelastography, TEG-MA = thrombelastography
maximum amplitude.
INTRODUCTION
D uring surgery the circulation is supported by a crystalloid,often saline or lactated Ringer solution (LR), eventually
supplemented by a colloid to delay when there is a need for
blood transfusion. In contrast to crystalloids, colloids stay
within the circulation and may even recruit fluid to the vascu-
lature.1 It therefore remains an option to administer a colloid to
bleeding patients perioperatively.2–4 On the other hand, syn-
thetic colloids impair coagulation competence as exemplified
by the use of hydroxyethyl starch (HES 130/0.4) during major
surgery.5 A thrombelastography (TEG) analysis showed that
HES reduced clot formation and strength (maximal amplitude
[MA]) and doubled the perioperative blood loss when compared
to the use of LR.5 Similarly, administration of Dextran reduced
coagulation competence during cystectomy and clinically
important hemorrhage (>1.5 L) appeared more often among
the patients who received Dextran than LR.6
Human albumin (HA) might be expected to affect coagu-
lation competence minimally but a meta-analysis addressing
cardiac surgery7 found increased perioperative bleeding and
need for transfusion with the use of albumin compared toxyethyl starch (HES 130/0.4). Albumin
activation and release of inflammatory
er meta-analysis found blood loss and
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need for blood transfusion increased by about 30% among
patients who received HES 130/0.4 rather than albumin.10
One randomized controlled trial compared the effect of admin-
istration HA and LR during major surgery and found similar
blood loss in the 2 groups of patients and yet increased need for
transfusion of blood in the albumin treated group.11
The present randomized controlled study aimed to further
explore the relationship between the perioperative blood loss
and coagulation competence during cystectomy with the use of
either HA or LR to support the circulation. The hypothesis was
that HA affects coagulation competence to such an extent that it
increases the blood loss as compared to use of LR. In addition,
we tested the hypothesis that TEG analysis is superior to predict
the blood loss compared to plasma coagulation variables.
MATERIALS AND METHODS
Trial Design
This randomized controlled trial was approved by Clin-
icalTrials.gov (NCT02270723), the Danish Health and Medi-
cine Authority (EudraCT 2013-005350-29), and the local Ethics
Committee in the Capital Regional of Denmark (H-1-2013-142)
and was registered by the Danish Data Protection Agency. The
trial was monitored by the Agency for Good Clinical Practice at
the University of Copenhagen and the Declaration of Helsinki
Rasmussen et alcriteria were followed.12
Conduct of the trial and the safety of the participants were
overseen by the authors who gathered the data that remained
FIGURE 1. Consort study flow diagram.
2 | www.md-journal.comconfidential throughout the process. The authors were involved
in all stages of manuscript generation and vouched for com-
pleteness and accuracy. No third party influenced the study
design, data analysis, or reporting.
Screening and randomization took place between April 8th
2014 and July 8th 2015. At least 24 hours before surgery written
informed consent was obtained from the patients. We excluded
patients from this investigator-initiated, prospective, blinded
trial if consent was withdrawn. Forty patients scheduled for
elective cystectomy were randomized to receive the recom-
mended maximum volume (25mL/kg) of either HA (Albumin,
human, CSL Behring, GmbH, Marburg, Germany) or LR by
computer-generated allocation sequence without blocks pro-
duced by the biostatistics Department (Figure 1). We included
patients older than 18 years scheduled for elective cystectomy
with no history of heart or hepatic insufficiency, disability of
coagulation, intracerebral hemorrhage, or hemodialysis. If a
patient used medication that was considered to affect coagu-
lation competence, that medication was paused 5 days prior to
surgery according to national guidelines.13
Interventions
The primary design of intervention has been published
previously.5,6 An intravenous line flushed with the randomized
Medicine  Volume 95, Number 9, March 2016fluid was placed in an opaque bag together with the intravenous
set to blind the surgical nurse who recorded the volume of lost
blood. The patients were in general anesthesia by remifentanil
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
and propofol administration and monitored with a periphery
arterial catheter connected to Nexfin device besides a central
venous and epidural catheter – the latter for postoperative pain
treatment.14
Normovolemia was established according to ‘‘goal
directed fluid therapy’’ (GDT) criteria.15 Hemodynamic data
were recorded after induction of anesthesia and insertion of the
arterial catheter (T0), before start of surgery (T1), after resection
of the urinary bladder (T2), at the end of anesthesia (T3), and 2
hours thereafter in the recovery room (T4).
Arterial blood specimens were analyzed by TEG16 and we
also analyzed blood specimens for hemoglobin, creatinine,
plasma coagulation, and blood gas variables. Both groups of
patients received either LR or SAGM if considered in need after
infusion of the allocated fluid (nonstudy fluid). Fluid balance
was determined at T2, T3, and T4. The very same 2 surgeons
carried out the operative procedures.
The primary outcome variables were coagulation compe-
tence besides the perioperative blood loss. We also compared
the use of HA and LR on patient outcome (need for post-
operative treatment of cardiopulmonary, infectious, or surgical
complications). A straight postoperative track was defined as
length of hospital stay 7 days without complications
requiring treatment.
Statistical Methods
Patients were analyzed in the group to which they were
Medicine  Volume 95, Number 9, March 2016assigned (Table 1). The sample size was based on data from the
study comparing the effect on hemorrhage during cystectomy
with the use of HES 130/0.4 versus LR. In that study, the blood
TABLE 1. Patient Characteristics and Baseline Laboratory Values
All Patients (n¼ 39) A
Preoperative status
Age, years 69 (9) (66–72) 69
Males gender (n) 25 (64%) 12
Body weight, kg 78 (14) (74–83) 77
ASA (>2) 6 (15%) 3
Cardiopulmonary disease (n) 18 (46%) 8
TEG
R-time, minute 4.7 (1.3) (4.3–5.1) 4.8
Angle, degrees 72 (6) (70–74) 71
MA, mm 65 (6) (62–67) 62
Ly30, minute 1.6 (2.0) (0.9–2.2) 2.1
Biochemistry
Platelets count, n/L 241 (68) (219–264) 238
Fibrinogen, mmol/L 10.8 (2.6) (9.9–11.6) 10.6
aPPT, second 29.1 (3.8) (27.9–30.3) 30.1
INR 1.07 (0.1) (1.05–1.10) 1.06
Perioperative variables
Anesthesia time, minute 249 (165–375) 260
Ephedrine, mg 30 (0–65) 23
Complications (n) 13 (33%) 6
Reoperations (n) 6 (15%) 3
Hospital stay, days 7 (3–90) 8
Straight postoperative track 19 (49%) 9
Values are either numbers (n), percentages (%), mean for normally distri
range for skewed data. P-value by univariate analysis. TEG R-time (rat
thromboplastin time, ASA¼American Society of Anesthesiologists, INR
thrombelastography, TEG-MA¼ thrombelastography maximal amplitude.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.loss was 2181 versus 1370mL with an SD of 1190 versus
603mL.5 The study was powered to detect a difference in blood
loss of 800mL between administration of HA and LR with a 2-
sided alpha level of 0.05 and a power of 80% for t-test with
correction for multiple comparisons. Consequently, a sample
size of 20 patients per group was included.
The statistical analyses were performed before breaking
the randomization code, and data were analyzed from the
modified intention-to-treat population, defined as all randomly
assigned patients except for those who could be excluded
without the risk of bias (Figure 1). We used 2-sided or unad-
justed Chi-square tests with odds ratio (OR), t-test, and Fisher
exact test for continuous and dichotomous variables, respect-
ively (SPSS version 20.0). Evaluation of differences was per-
formed using x2 test for categorical data and analysis of
variance or Mann–Whitney U-test and Wilcoxon signed ranks
test for continuous data when appropriate. Results are presented
as mean (SD) or median with range for skewed variables and a
2-sided P value< 0.05 was considered to indicate statistical
significance. Correlations were evaluated by Spearman coeffi-
cient. A backwards multivariate linear regression analysis with
Bonferroni correction for multiple comparisons was performed,
including variables that were either found to be correlated with
or expected to influence TEG and plasma hemostatic variables
that were independently associated with albumin infusion
during anesthesia. The variables included in the multivariate
analyses were TEG-angle, TEG-maximum amplitude (TEG-
Impact of Albumin on Coagulation Competence and HemorrhageMA), platelets, fibrinogen, aPPT, and INR. Results are pre-
sented as regression coefficients (b) with 95% confidence
interval and t and P values.
and Perioperative Events
lbumin (n¼ 19) Lactated Ringer (n¼ 20) P Value
(10) (64–73) 69 (8) (66–73) 0.84
(63%) 13 (65%) 0.91
(15) (70–84) 80 (12) (74–86) 0.48
(16%) 3 (15%) 0.73
(42%) 10 (50%) 0.75
(0.8) (4.0–5.6) 4.6 (0.8) (4.2–5.0) 0.73
(8) (67–75) 73 (4) (71–74) 0.38
(6) (59–65) 67 (6) (64–69) 0.05
(2.4) (0.9–3.2) 1.1 (1.4) (0.4–1.8) 0.13
(82) (199–278) 244 (54) (219–269) 0.79
(2.4 (9.5–11.8) 10.9 (2.9) (9.5–12.2) 0.78
(4.5) (27.8–32.3) 28.3 (2.8) (27.0–29.5) 0.14
(0.1) (1.02–1.10) 1.08 (0.1) (1.04–1.12) 0.53
(165–375) 239 (165–300) 0.16
(0–40) 37 (0–65) 0.004
(32%) 7 (35%) 0.82
(16%) 3 (15%) 0.95
(5–90) 7 (3–20) 0.27
(47%) 10 (50%) 0.87
buted variables with SD and 95% confidence interval, or medians with
e of clot initiation), TEG angle (clot growth). aPPT¼ active partial
¼ international normalized ratio, Ly30¼Lysis after 30min, TEG¼
www.md-journal.com | 3
RESULTS
There was no significant intergroup difference in baseline
data including preoperative diseases between the 2 groups of
patients (Figure 1 and Table 1). After induction of anesthesia, 3
patients (16%) in the albumin group were intravascular hypo-
volemic according to GDT criteria as compared to 1 patient
(5%) in the crystalloid group (P¼ 0.34). In the colloid group,
patients received 23.5mL/kg (1125–2500)mL HA and 4
patients did not receive the full scheduled volume, because
they were considered hemodynamic stable before the intended
volume (25mL/kg) was infused.
Fluid Administration and Blood Loss
The perioperative blood loss was 1658 (800–3300)mL in
the albumin group and not significantly different in the LR
group: 1472 (700–4330)mL, P¼ 0.45, Table 2. Furthermore,
the number of patients exposed to what we considered a
significant blood loss (>1500mL) was similar in the albumin
and in the LR group: 6 patients (33%) versus 5 patients (28%),
P¼ 1.00. Table 2 also presents the IV administration of study
and nonstudy fluids. Transfusion was initiated at a hemoglobin
of 3.8 to 5.5mmol/L and the transfusion of packed red blood
cells was 235 (0–980) versus 80 (0–1100)mL in the albumin
and LR group, respectively (P¼ 0.14). Thus, 6 patients (33%)
in both groups were provided with blood transfusion.
The fluid balance was positive by 1095 (400–2460)mL in
the albumin group and by 1687 (415–2850)mL in the LR group
(P< 0.001), also with more patients in the LR group having a
positive fluid balance that we considered significant, that is,
exceeding 2000mL: 9 patients versus 1 patient, OR¼ 14.7
(1.6–132.6), P¼ 0.016. Furthermore, the albumin group
received less ephedrine than the LR group, 23 (0–40)mg versus
37 (0-65)mg, P¼ 0.004).
Rasmussen et alHemodynamics
During anesthesia changes in MAP were similar in the 2
groups of patients, whereas HR increased more in the LR group
TABLE 2. Perioperative Fluid Administration, Blood Loss, and
Fluid Balance (mL) in 2 Groups of Patients Undergoing Cystect-
omy
Albumin
(n¼ 19)
Lactated
Ringer
(n¼ 20)
P
Value
Intravenous fluids
Lactated Ringer 711 0–2000 2819 400–4075 <0.001
Albumin 1892 1125–2500
Packed red
blood cells
235 0–980 80 0–1100 0.14
FFP 56 0–540 215 0–1100 0.12
Blood loss 1658 800–3300 1472 700–4330 0.45
Fluids balance
Fluid infusion 3168 2050–5190 3514 2470–6175 0.21
Fluid lost 2020 1030–3600 1828 1000–4880 0.47
Fluid balance 1095 400–2460 1687 415–2850 <0.001
Fluid balance calculated from the administered solutions, transfusion
of blood products, urine output, and blood loss (suction and drainage)
during anesthesia and in the recovery room. Blood products included
packed red blood cells, and fresh-frozen plasma (FFP).
Values are expressed as mean with range. P-value by univariate
analysis.
4 | www.md-journal.com(68 18 to 81 10) beats/min compared to the albumin group
(67 15 to 68 14) beats/min, P< 0.002. SV increased in the
albumin group (61 14 to 76 13)mL/beats compared to LR
group (67 14 to 66 14)mL/beats, P¼ 0.038; however, CO
was not significantly different between the 2 groups of patients.
Coagulation
The baseline values of TEG and biochemistry variables are
given in Table 1. After cystectomy (T2) in the LR group, TEG-
angle increased to 74 3 compared to 69 5 degrees in the
albumin group, P< 0.01. The lowest values of TEG-MA was
observed in the albumin group (60 7 vs 68 6)mm,
P< 0.002. APPT decreased in the LR group to 27.9 2.7
and to 31.4 3.9 seconds in the albumin group, P< 0.003.
There was no significant differences between the groups regard-
ing R-time, Lysis after 30min (Ly30), platelets, INR, or coagu-
lation factor II, VII, X.
At the end of anesthesia (T3) TEG-angle in the LR group
increased to 74 5 compared with 69 5 degrees in the
albumin group, P< 0.003. The lowest values of TEG-MA
was observed in the albumin group (59 6 vs 67 6)mm,
P< 0.001. Platelets decreased in both groups of patients, mainly
in the albumin group (185 51) 109/L compared to the LR
group (232 49) 109/L, P< 0.008. APPT decreased in the LR
group to 26.0 32.7 seconds compared to the albumin group
31.8 6.2 seconds, P< 0.001, and INR increased more in the
albumin group (to 1.34 0.20) compared with the LR group (to
1.14 0.10), P< 0.001. There was no significant difference in
R-time and Ly30, between the groups of patients.
In the recovery room (T4) in the LR group, the TEG-angle
was 74 4 compared with 71 4 degrees in the albumin group,
P< 0.03. The lowest values of TEG-MA was observed in the
albumin group compared to the LR group (60 6 vs
65 7)mm, P< 0.008. Platelets decreased in both groups of
patients, mainly after albumin (185 51 vs 223 48) 109/L,
P< 0.03. APPT decreased in the LR group to 25.0 3.2 sec-
seconds compared to the albumin group (30.6 4.9) seconds,
P< 0.001, whereas INR increased more in the albumin group
(to 1.26 0.10) compared with the LR group (to 1.14 0.08),
P< 0.001. Likewise, in the recovery room, the R-time and Ly30
were without differences between the groups. The decrease in
hemoglobin was not significantly different in the albumin group
compared to the LR group (7.4 1.3 to 5.9 0.8) versus
(7.8 1.1 to 6.4 1.1)mmol/L, P< 0.12.
Correlations
Correlation between blood loss and albumin infusion
during anesthesia versus coagulation variables is shown in
Table 3. The changes in TEG-angle and TEG-MA from T1
to T3 were correlated to administration of albumin as was
plasma coagulation variables. The perioperative blood loss
was related to TEG-angle, TEG-MA, and platelets, whereas
R-time, Ly30, aPPT, and INR demonstrated poor correlations.
Multivariate Linear Regression Analysis of the
Association between Hemorrhage, Albumin
Administration Versus Coagulation Competence
Independent association between bleeding and albumin
infusion compared to reduced coagulation competence was
evaluated by multivariate linear regression, including only
Medicine  Volume 95, Number 9, March 2016univariate significant variables. The blood loss was indepen-
dently associated with reduced TEG-MA, while both reduced
TEG-MA and the biochemistry variables: aPPT and INR were
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Spearman Correlation of Changing in (TEG Values
and Plasma Coagulation Tests (from T1 to T3) Related to
Perioperative Bleeding and Albumin Administration in the
Randomized Trial
Bleeding Albumin Infusion
r P r P
TEG angle S0.34 0.03 S0.33 0.03
TEG-MA S0.36 0.02 S0.40 0.01
TEG R-time 0.26 0.11 0.15 0.37
Ly30 0.12 0.47 0.04 0.80
Platelets count S0.38 0.02 S0.48 0.002
Fibrinogen 0.28 0.08 S0.47 0.003
aPPT 0.10 0.51 0.40 0.01
INR 0.22 0.19 0.63 <0.001
TEGR-time (rate of clot initiation, minutes); TEG angle (clot growth,
degrees). aPPT¼ active partial thromboplastin time (seconds),
INR¼ international normalized ratio, Ly30¼Lysis after 30min,
FIGURE 2. Correlation between TEG-MA and blood loss. Change
in plasma TEG-MA from start (T1) to end of anesthesia (T3) in
patients receiving lactated Ringer solution (~) or albumin (),
r¼0.36 (95% CI 0.62 to 0.10), P¼0.02 Regression lines
Medicine  Volume 95, Number 9, March 2016 Impact of Albumin on Coagulation Competence and Hemorrhageindependently associated with albumin infusion (Table 4,
Figure 2).
Outcome
The postoperative course and number of treated compli-
cations were similar in the 2 groups of patients (Table 1).
TEG¼ thrombelastography, TEG-MA¼ thrombelastography maximal
amplitude (mm).DISCUSSION
This randomized controlled study used either HA or LR to
support the circulation during cystectomy according to
TABLE 4. Multivariate Linear Regression Analyses of Associ-
ation Between Perioperative Bleeding and Administration of
Albumin Evaluated by TEG and Conventional Plasma Coagu-
lation Variables (Changes from T1 to T3)
b (SE)
95%
CI for b T P-Value
Bleeding
TEG angle 0.02 (0.01) 0.01–0.06 1.15 0.26
TEG-MA 0.02 (0.01) 0.05–0.0011.30 0.042
Platelets count0.009 (0.002)0.004–0.002 0.61 0.54
Albumin administration
TEG angle 0.01 (0.04) 0.08–0.09 0.19 0.85
TEG-MA 0.08 (0.04) 0.15–0.0092.27 0.029
Platelets count0.005 (0.003) 0.01–0.001 2.23 0.09
Fibrinogen 0.01 (0.11) 0.24–0.21 0.13 0.89
aPPT 0.05 (0.02) 0.01–0.10 2.38 0.022
INR 2.96 (1.51) 0.27–5.81 2.25 0.033
Regression coefficients (b) with SE; t and P-values displayed for
the multivariate model. Multivariate linear regression models includ-
ing only univariate significant variables from Table 3. TEG angle
(clot growth, degrees). . aPPT¼ active partial thromboplastin time,
CI¼ confidence interval, INR¼ international normalized ratio,
SE¼ standard errors, TEG¼ thrombelastography, TEG-MA¼
thrombelastography maximal amplitude.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.individualized goal-directed principles without demonstrating
significant difference in perioperative bleeding or on outcome.
Yet, perioperative hemorrhage was related to the TEG variable
MA, but not to plasma coagulation variables.
Even though albumin is the most abundant protein in
plasma and administration to patients therefore might be con-
sidered to be safe, there has been concern about the use of
albumin to support the circulation during surgery. HA has been
used without reports of viral infections,17 but in a systematic
review including 1419 critically ill patients in 30 studies, the use
of albumin seemed to increase mortality.18 Yet, the use of
albumin was not mentioned in the comments from European
Medicine Agency on the use of colloids and there has been no
suggestion of banning albumin solutions.19 Albumin does not
affect outcome, including mortality, in intensive care when
compared to the use of saline.20 In support, blood loss during
cardiac surgery is similar when administering albumin and
LR.11 In contrast to the experience from cardiac surgery, the
present study did not demonstrate increased need for adminis-
tration of blood products with the use of albumin.
In this randomized controlled study comparing adminis-
tration of LR versus albumin, both TEG-angle, TEG-MA and
plasma coagulation variables were correlated to albumin infu-
sion (Table 3), and these variables were used in the Spearman
correlation analysis to design a multivariable regression
analysis. Changes in TEG-MA and the biochemistry variables
aPPT and INR were the only independent variables associated
with infusion of albumin in line with the data from Skhirtladze
et al11 who showedmaximal clot firmness lower in the albumin
compared to LR group when assessed in a postoperative
evaluation.
Evaluation of coagulation competence remains
debated.21,22 For trauma patients it is recommended that
TEG rather than conventional plasma coagulation tests is used
because TEG allows for a fast result23 and here the blood loss
was correlated to TEG-MA rather than to plasma
coagulation variables.
shown with 95% confidence interval. CI¼ confidence interval,
TEG-MA¼ thrombelastography maximal amplitude.It may seem an advantage to administer albumin rather
than LR as the postoperative fluid balance was 54% higher
(1095 vs 1687)mL, P< 0.001 in the LR group. A positive
www.md-journal.com | 5
postoperative fluid balance has been related to gut edema and
may contribute to intestinal dysfunction, postoperative compli-
cations and therefore extended hospital stay.24,25 On the other
hand, the volume balance that maintains the central blood
volume during and after surgery has not been determined.
We suggest that such an evaluation is made, for example, by
echocardiographic determination of ventricular filling or deter-
mination of which volume load that would maintain plasma
atrial natriuretic peptide as an indication of a stable central
blood volume.26
There are limitations to this investigation. The volume
used for GDT influences the estimate of the deficit. We used
200mL, reflecting the volume used in most RCT studies, but the
volume may be related to the weight, body mass index, age, and
health of the patient.27 Besides, the study has a short observation
period and a larger cohort may be needed to evaluate an effect of
albumin versus LR on complications and survival.
CONCLUSION
The results suggest that the perioperative use of 5% HA
compared to LR to support the circulation during cystectomy
reduces the postoperative volume surplus but affects coagu-
lation competence, but not to an extent that albumin affects
bleeding or outcome measures. The results suggest that the
perioperative use of 5% HA compared to LR only affects
coagulation competence and blood loss little during major
surgery. Also the use of HA reduced the postoperative volume
surplus, but not the incidence of postoperative complications, or
hospital stay.
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